14 ture so much that the reaction comes to a standstill, and to reach this low temperature so speedily that there is no time for damage. This can indeed be achieved and when small samples of red cells packed in thin metal containers are, for example, immersed into a -70°C cooling mixture the time is too short for all the free water to leave the cells and to form extracellular crystals. However, the intracellular ice crystals formed under these conditions will damage the cells physically. Thus rapid freezing by-passes the chemical damage by high intracellular solute concentration but causes the physical damage by which cells are disrupted by intracellular ice crystals.
Ultra-rapid Freezing By speeding the cooling still further from a rapid to an ultra-rapid speed it can be arranged that the intracellular crystals have no time to grow to any appreciable size and remain too small to cause much physical damage. Dangerous intracellular crystal growth occurs between 0°and -50°C (Luyet & Hartung 1941 , Strumia 1949 . In ultrarapid freezing this temperature is passed within a few thousandths of a second, and the way to achieve this is to immerse very small samples into liquid nitrogen which has a temperature of -1960 C. To enable the freezing to proceed so speedily the samples have to be very small, otherwise heat conduction will require a longer time than a few milliseconds. Luyet & Hartung (1941) spread an erythrocyte film on a cover slip and immersed this into liquid nitrogen. Meryman & Kafig (1955) sprayed tiny droplets into liquid nitrogen because these have a maximal surface: volume ratio.
Protection against Damage by Rapid Freezing
This ultra-rapid procedure requiring milliseconds can be extended to 15-20 seconds when sugars are added to the blood. This allows the freezing of larger bulks than thin blood films or minute droplets of less than 1 mm in diameter. The effective thickness of a drop of blood or of a layer of blood could be raised to 4 mm provided sugars of various types or even small-molecular carbohydrates such as dextran or polyvinylpyrrolidone (PVP) are present. Florio et al. (1943) used 1000 glucose, Strumia et al. (1960) used 0 5 molar (about 10%) mixtures of lactose and glucose. Early in 1960 a study of the freezing of red cells in liquid nitrogen was undertaken at the request of the Director General of the Army Medical Services and the beneficial effect of glucose and, better still, sucrose was independently observed. Blood was mixed with EDTA and then with 0-5 vol. of 4000 (w/v) of sucrose (Huntsman et al. 1960) . It was noted that the blood group antigens were unaffected. Two years' experience in the keeping properties of blood frozen in this way has now accumulated (Huntsman et al. 1962 (Huntsman et al. , 1963 . There is an almost perfect preservation of blood group antigens, but the concentrations of the enzyme aldolase which is known to fall rapidly on storage at +4°C also decreases even at -196°C. This fall in enzyme activity is of course very much less rapid at the temperature of liquid nitrogen than at +4°C, yet after two years only 50% of the original activity was present.
Royal Army Medical College, Millbank, London) Any long-term preservation process used to stockpile blood for emergency use must fulfil certain basic requirements if it is to function effectively under disaster conditions. Large quantities of blood will be required quickly when time, thawing equipment and technical skill will be in short supply.
It is suggested that a process for this situation should enable the frozen stocks of blood to be thawed quickly with simple equipment and used at once without any post-thaw processing being necessary. Apart from the actual freezing, storage and thawing stages, a long-term preservation process may involve any of the following operations: (1) Special methods of blood collection.
(2) Removal of plasma. (3) Addition of agents for cell protection. (4) Removal of additive. (5) Resuspension of the cells in an appropriate medium.
The slow freezing processes using glycerol or dimethylsulphoxide offer the advantage that products of hemolysis are removed as well as the additive in the post-thaw processing; however, if the blood has to be capable of immediate use after thawing, this advantage is nullified. Thus the rapid freezing processes using additives which can be transfused with the blood would seem better adapted to emergency use.
Equipment
The technique used to achieve rapid rates of heat transfer during the freezing and thawing of pint quantities of blood has been described by Rinfret (1963) . This utilized a special corrugated blood container approximately 25 cm square, but only 19 mm in cross-section, so producing a large surface to volume ratio. A pint of blood does not fill the container completely, so that, during freezing, agitation of the container at a rate sufficient to distribute the blood over the interior surface, produces a uniform 'shell' of frozen blood with a central space occupied by frozen foam. Smaller containers enabling quantities less than a pint to be frozen have also been developed.
Heat transfer rates during cooling in liquid nitrogen can be increased by applying thermally insulating films to the exterior surface of the container (Cowley et al. 1961) . By using a material such as polyvinylpyrrolidone (PVP) which is soluble both in volatile organic solvents and in water, an insulating film can be produced, which washes off and so does not interfere when the containers are thawed in a warm water bath. Static thawing relying entirely on convection does not allow sufficiently rapid rates to be attained and shaking is again used so as to produce forced circulation inside the container. The main problem associated with thawing is the diminishing temperature gradient which is available as the frozen blood warms up, and hence comparatively high thaw-bath temperatures have to be employed to attain an adequate rate of heat transfer. By limiting the thawing time, however, the blood can be prevented from actually reaching the thaw-bath temperature. Thawing time, thawbath temperature and agitation speed are all interrelated, and the blood processing unit used for manipulating the containers during freezing and thawing enables these parameters to be accurately controlled over a wide range.
Technique
After much screening of potential compounds, the additive which has to date provided one of the best combinations of efficiency and acceptability is PVP. Its use for cell protection was first described by Bricka & Bessis (1955) and since then a great deal of research has focused on the relation between molecular size and efficiency as a cell protector. It appears that protective ability is directly related to molecular size so the material used should have as large a molecular size as possible, compatible with clinical acceptability. The material used here has been K30 PVP (average molecular wt 40,000) but some experiments have been carried out to assess the relative efficiency of K17 PVP (average mol. wt. 12,600).
Approximately 40 g of PVP are required for freezing 500 ml of blood. To simplify sterile tec.hnique as far as possible, the additive solution has been autoclaved in situ in the containers, so that the blood only requires adding and careful mixing. This raises the objection that the first few millilitres of blood to enter will be exposed to a high concentration of PVP which may have a crenating and possible damaging effect. One method, which is under investigation, of obviating this is to allow the red cells to separate and mix the plasma with the PVP before the red cells are added. An antifoam agent is added to the PVP in an attempt to cut down foaming which occurs when blood is shaken.
Several alternative methods are available for adding the blood to the container prior to freezing, for example: (1) Addition of ACD blood collected routinely in a pack or bottle. (2) Addition of blood which has been collected by passage through an ion-exchange column. (3) Direct donation from donor into the container. This requires inclusion of an anticoagulant with the PVP solution, and the progress of donation has to be assessed by weighing on a spring balance.
The insulating coating on the containers is produced by dipping them in a solution of PVP in methylated spirits and allowing fifteen minutes for drainage of the excess solution and evaporation of the solvent. To ensure a grease-free surface and good adhesion of the PVP, containers are washed in a detergent solution immediately prior to coating them.
Storage of the frozen containers has been in the vapour phase of a liquid nitrogen storage cabinet (Linde LNR 640).
Duration of storage has varied between three weeks and fifteen months but the majority of the pints studied were stored for approximately six months.
Stout leather gloves are adequate for handling the containers inside the storage cabinet and for removing them for thawing. A water bath is temperature of 45°C enables thawing times of the order of a minute to be employed.
Results
Htemolysis has been assessed using the following formula: It has been customary in this work to refer to cell recovery, i.e. the percentage of intact cells recovered after thawing.
Recovery= 100-% hemolysis.
Cell recovery in the blood used in clinical trials: Most of the blood frozen in the laboratory at the Royal Army Medical College has been collected in Fenwal bags and transferred to the cryogenic containers through standard transfusion sets. The usual interval between donation and freezing has been twenty-four hours.
In 48 pints of blood thawed over a period of six months the mean cell recovery was 96 7 %; all values fell in the range of 95 5 % to 98 %. K17 PVP: With K 17 PVP used in the same concentration as the K30 PVP of the previous series red cell recovery in four typical specimens was 90%, 91 %, 90% and 92%. Under a variety of conditions the K17 PVP was inferior to the extent of approximately 5 % in cell recovery.
Ion-exchange anticoagulant: Blood collected by passing it through an ion-exchange column to prevent coagulation has been used in low temperature preservation experiments. This method of preventing coagulation causes minimal alterations to the blood as opposed to collection in ACD which adds water, glucose and additional ions.
In a preliminary trial four pints of blood were collected in a blood pack (Fenwal JB-2) which incorporates an ion-exchange column for the removal of calcium ions. Freezing and thawing were carried out by the same technique as for ACD blood. The red cell recovery in the four specimens was 97 5 %, 98 5 %, 98 % and 97 %.
Allowing for donor and process variation, this result could have been obtained by the usual technique employing ACD; so, to reduce the need for further sampling, donor variation was removed by comparing samples from the same donor.
Direct comparison of ACD and ion exchange: Treated blood: The ion-exchange pack was used as before but only 250 ml was collected. Another 250 ml was then collected in 40 ml of ACD (USP formula A) after detaching the ion-exchange column.
'Split' samples of this type were taken from three donors, and the blood was frozen and thawed in half-pint containers using 20 g of K30 PVP.
Great care was taken to ensure that all operations were performed in exactly the same manner on all six specimens. Comparison of the recovery values is shown in Table 1 ; the figures are the average oftriplicate analysis. Under these experimental conditions the advantage of the ion-exchange collections is minimal. However, the ion-exchange technique is more efficient in that the final PCV is 40 % compared to the 35 % of the ACD blood. Direct donation: The final example selected is a logical evolution from the previous methods and consists of bleeding the donor directly into a PVP solution which is made up in ACD solution instead of distilled water. This avoids the excessive dilution of the blood which occurs when PVP and ACD are employed as separate solutions. In practice the PCV obtained was 40 %.
The major drawback to this method is that the first part of the collection has to enter a high concentration of PVP with the possible effects mentioned previously.
Recovery values obtained by this technique in four specimens processed as for the previous examples were 97 %, 97 %, 96-5 % and 97s5 %.
Discussion
Most of the blood used in this work has been collected in plastic packs containing 75 ml of ACD anticoagulant (USP formula A). Occasionally National Blood Transfusion Service bottles have been employed containing 120 ml of anticoagulant. In this latter case when the volume of the PVP solution is included the volume of added fluid approximates to half of the blood which is being processed. This is reflected in the PCV which falls to about 30 % compared to the normal figure of 45 %. This disadvantage may be apparent rather than real in the type of case where blood volume replacement is as important as red cell replacement. However, if the rather lower PCV and hence total hTmoglobin content is considered undesirable, alternative methods are available to cover this need.
Although the equipment used is of considerable complexity this is in no way contrary to the requirements set out in the introduction. This complexity stems from the design concept as a research tool for investigating a range of parameters under laboratory conditions. A unit designed for the practical application of established principles could be simple and compact. A conservative estimate of the capabilities of such a single unit is 25 pints thawed per hour. Equipment designed specifically for the storage and transport of frozen blood is not currently available but its construction is quite feasible with modern technology.
The degree of hmemolysis produced by this method of storage is sufficient to produce a plasma potassium level of approx 20 mEq/l. and a free haemoglobin level of 400-500 mg/100 ml of plasma in the thawed product. It is suggested that these figures should be interpreted in terms of what is acceptable under emergency conditions rather than by the standards of peace-time blood banking practice.
Summary
The aim of this paper has been to present some of the data which have been obtained with a longterm blood storage process suitable for emergency use. The average cell recovery of 48 pints of thawed blood produced for clinical trial has been 96-7 %. Reports of the clinical assessment of the storage process will be presented separately.
Colonel H W Whitcher (Royal Army Medical College,
Millbank, London)
The aim of the Army Medical Services in the matter of the long-term preservation of blood is simple. It is that a process should be available whereby blood, collected and grouped under peace conditions, can be frozen and stored indefinitely. Then in the event of an emergency or disaster, the blood will only need thawing to be ready for immediate transfusion. It is further considered that stocks of blood must be capable of being stored for up to two months and then thawed in the absence of any electricity supplies.
Following upon in vitro and animal work on blood preserved by the liquid nitrogen process (LNP) it was considered necessary finally to prove its value by clinical work. In the course of this, two aspects particularly demanded attention. One of these was the free potassium (K+) state of the processed blood relative to normal National Blood Transfusion Service blood. The other was the relationship between the free plasma hEemoglobin (Hb) and the haptoglobins (Hp), of the patient's blood before and after transfusion.
A series of pints of processed blood was studied from the time of thawing during each of twenty-one days and similar studies were made on normal bank blood from the time of collection, for twenty-one days. It was found that the K+ level of the processed blood was 16 mEq/l. on the day of thawing, rising through 19 mEq/l. two days after thawing to 26 mEq/l. on the twenty-first day.
Banked blood showed a K+ level of 5 mEq/l. on collection rising steadily to a level of 25 mEq/l. on day 21.
It is considered that under emergency conditions processed blood would be given to a patient within forty-eight hours of thawing, and the K+ level of this blood would be between 16 and 19 mEq/l. This level of K+ approximates to that found in normal bank blood stored in a blood refrigerator for ten to fourteen days, which is the age at which a high percentage of ordinary transfusion blood is used.
The very paucity of reliable information on the Hb-Hp complex in man when the plasma Hb is high was justification for studying the complex. Samples of blood were taken between 0 and 72 hours following transfusion. It was found that even where plasma hemoglobin level rose to 120 mg/100 ml, clearance of excess plasma hemoglobin occurred within twelve hours of the completion of the transfusion.
Of particular interest was the speed of regeneration of the haptoglobins. It had started within four hours, was about half-way at twenty-four hours and was substantially normal in seventytwo hours. This speed of regeneration could be a matter of importance if repeated transfusions are anticipated.
No clinical studies of a transfusion fluid would be satisfactory without some concomitant biochemical studies. This has been true in the clinical studies of LNP blood where consideration has to be given to: (1) Selection of subjects. (2) Grouping and cross-matching. (3) Composition of transfusion material. (4) Parameters to be studied. (5) Results.
